US Patent Issued to BEIJING TIDE PHARMACEUTICAL on Dec. 30 for "P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,479, issued on Dec. 30, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof" was invented by Yanping Zhao (Beijing), Hongjun Wang (Beijing), Gong Li (Beijing), Xiang Li (Beijing), Yuanyuan Jiang (Beijing), Kai Liu (Beijing), Yeming Wang (Beijing), Liying Zhou (Beijing), Yanan Liu (Beijing), Ning Shao (Beijing) and Fengping Xiao (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventin...